TheEdgeResearch
Home / Stocks / MLAB

Mesa Laboratories, Inc. (MLAB)

NASDAQ Healthcare Medical - Specialties
$128.25 ▲ +7.50%
Market Cap
$717.7M
Sector
Healthcare
Industry
Medical - Specialties
Beta
1.07
52-Wk Range
69.51-144.35
CEO
Siddhartha C. Kadia
Country
US
Currency
USD

Mesa Laboratories, Inc. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Lakewood, CO, US. The stock last traded at $128.25, up 7.50% on the session, giving a market capitalisation of $717.7M. On trailing twelve-month figures it carries a trailing P/E of 149.13, a net margin of 1.9%. Its beta of 1.07 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
149.13
Price / Sales
2.87
Price / Book
3.84
EV / EBITDA
19.43
Gross margin
66.0%
Operating margin
9.0%
Net margin
1.9%
Return on equity
—
Debt / equity
0.54
Current ratio
2.07
Dividend yield
0.5%
Payout ratio
73.6%
Company profile
Exchange
NASDAQ
Employees
717
IPO date
1984-02-29
Headquarters
Lakewood, CO, US
About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Comparable companies

Mesa Laboratories, Inc. is most often compared with the following Healthcare names:

ABIOLABMRVIPACBQGENRVTYTECHTMOTXG
More research on MLAB
MLAB technical analysis MLAB TheEdge Score Compare against peers
Open full interactive analysis & DCF →